The Alzheimer's disease research community is in a great deal of flux at the moment. After a series of high-profile clinical trial failures, debate rages over whether the current causal hypothesis for the disease is correct. A new study has revealed novel insights into the early stages of the disease's development and suggests treatment may only be effective if delivered before a person becomes symptomatic.
.. Continue Reading Administered early, an already approved drug may help stop Alzheimer’s progressionCategory: Medical
Tags:
from New Atlas https://ift.tt/2Kse00B
No comments:
Post a Comment